Trials / Sponsors / Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population Hypertension | Phase 1 | 2025-10-05 |
| Recruiting | Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors Cancer, Neoplasms, Neoplasms, Breast | Phase 1 / Phase 2 | 2024-10-30 |
| Unknown | Study of TFX06 in Women With Advanced Breast Cancer. ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer | Phase 1 / Phase 2 | 2023-04-17 |
| Unknown | A Study of TFX05-01 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2022-06-05 |